This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Cancer Center. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Cancer Treatment by Sung Sik Han
Introduction
Sung Sik Han is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions. His work focuses on creating effective therapies for pancreatic cancer, a disease that poses significant challenges in medical treatment.
Latest Patents
Sung Sik Han holds a patent for a pharmaceutical composition aimed at preventing and treating pancreatic cancer. This composition includes gossypol and phenformin as active ingredients. The patent describes a combination of anticancer agents that can create a synergistic effect when co-administered in cancer treatment. Specifically, the invention suggests that anticancer agents such as sorafenib, vemurafenib, irinotecan, cisplatin, paclitaxel, and doxorubicin, when used in a triple-drug combination with gossypol and phenformin, can significantly enhance the suppression of cancer cell proliferation and improve cancer cell death compared to mono-drug and dual-drug treatment groups.
Career Highlights
Sung Sik Han is affiliated with the National Cancer Center, where he conducts his research and development activities. His work is pivotal in advancing the understanding and treatment of pancreatic cancer, contributing to the ongoing efforts to improve patient outcomes in oncology.
Collaborations
He collaborates with esteemed colleagues, including Soo Youl Kim and Tae Hyun Kim, who share his commitment to cancer research and innovation. Their combined expertise enhances the potential for breakthroughs in cancer treatment.
Conclusion
Sung Sik Han's innovative approach to cancer treatment through his patented pharmaceutical composition exemplifies the critical role of research and collaboration in the fight against pancreatic cancer. His contributions are vital in paving the way for more effective therapies and improving the lives of patients battling this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile